It was observed that the level of antiapoptotic protein Bcl-2 was downregulated in NSCLC cells by DBG treatment, whereas the level of Bad and Bim increased (Figure 7(Fig. 7)). This evidence concerns the gene BCL2 and non-small cell lung carcinoma.